These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 30103998)

  • 1. Estimating the number of infections caused by antibiotic-resistant Escherichia coli and Klebsiella pneumoniae in 2014: a modelling study.
    Temkin E; Fallach N; Almagor J; Gladstone BP; Tacconelli E; Carmeli Y;
    Lancet Glob Health; 2018 Sep; 6(9):e969-e979. PubMed ID: 30103998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
    Antimicrobial Resistance Collaborators
    Lancet; 2022 Feb; 399(10325):629-655. PubMed ID: 35065702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global forecast of antimicrobial resistance in invasive isolates of Escherichia coli and Klebsiella pneumoniae.
    Alvarez-Uria G; Gandra S; Mandal S; Laxminarayan R
    Int J Infect Dis; 2018 Mar; 68():50-53. PubMed ID: 29410253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nosocomial bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae resistant to third-generation cephalosporins, Finland, 1999-2013: Trends, patient characteristics and mortality.
    Martelius T; Jalava J; Kärki T; Möttönen T; Ollgren J; Lyytikäinen O;
    Infect Dis (Lond); 2016; 48(3):229-34. PubMed ID: 26577519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Filling the gaps in the global prevalence map of clinical antimicrobial resistance.
    Oldenkamp R; Schultsz C; Mancini E; Cappuccio A
    Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33372157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends and relationship between antimicrobial resistance and antibiotic use in Xinjiang Uyghur Autonomous Region, China: Based on a 3 year surveillance data, 2014-2016.
    Wushouer H; Zhang ZX; Wang JH; Ji P; Zhu QF; Aishan R; Shi LW
    J Infect Public Health; 2018; 11(3):339-346. PubMed ID: 29017750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
    Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
    Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of bloodstream infections caused by extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae in Switzerland, 2015-2022: secular trends and association with the COVID-19 pandemic.
    Damonti L; Gasser M; Kronenberg A; Buetti N
    J Hosp Infect; 2024 Aug; 150():145-152. PubMed ID: 38838742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
    Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
    Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae: critical tools for antibiotic resistance pattern.
    Padmini N; Ajilda AAK; Sivakumar N; Selvakumar G
    J Basic Microbiol; 2017 Jun; 57(6):460-470. PubMed ID: 28397262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis.
    Antimicrobial Resistance Collaborators
    Lancet Glob Health; 2024 Feb; 12(2):e201-e216. PubMed ID: 38134946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality associated with third-generation cephalosporin resistance in Enterobacterales bloodstream infections at eight sub-Saharan African hospitals (MBIRA): a prospective cohort study.
    Aiken AM; Rehman AM; de Kraker MEA; Madrid L; Kebede M; Labi AK; Obeng-Nkrumah N; Nyamwaya B; Kagucia E; Cocker D; Kawaza K; Lester R; Iregbu KC; Medugu N; Nwajiobi-Princewill PI; Dramowski A; Sonda T; Hemed A; Fwoloshi S; Ojok D; Scott JAG; Whitelaw A;
    Lancet Infect Dis; 2023 Nov; 23(11):1280-1290. PubMed ID: 37454672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review on the excess health risk of antibiotic-resistant bloodstream infections for six key pathogens in Europe.
    Hassoun-Kheir N; Guedes M; Ngo Nsoga MT; Argante L; Arieti F; Gladstone BP; Kingston R; Naylor NR; Pezzani MD; Pouwels KB; Robotham JV; Rodríguez-Baño J; Tacconelli E; Vella V; Harbarth S; de Kraker MEA;
    Clin Microbiol Infect; 2024 Mar; 30 Suppl 1():S14-S25. PubMed ID: 37802750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in Expanded-Spectrum Cephalosporin-Resistant Escherichia coli and Klebsiella pneumoniae among Dutch Clinical Isolates, from 2008 to 2012.
    van der Steen M; Leenstra T; Kluytmans JA; van der Bij AK;
    PLoS One; 2015; 10(9):e0138088. PubMed ID: 26381746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is There an Association Between Use of Amoxicillin-Clavulanate and Resistance to Third-Generation Cephalosporins in Klebsiella pneumoniae and Escherichia coli at the Hospital Level?
    Marquet A; Vibet MA; Caillon J; Javaudin F; Chapelet G; Montassier E; Batard E
    Microb Drug Resist; 2018 Sep; 24(7):987-994. PubMed ID: 29489447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in antimicrobial resistance in Israel, 2014-2017.
    Dickstein Y; Temkin E; Ish Shalom M; Schwartz D; Carmeli Y; Schwaber MJ
    Antimicrob Resist Infect Control; 2019; 8():96. PubMed ID: 31171967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid Increase in Prevalence of Carbapenem-Resistant Enterobacteriaceae (CRE) and Emergence of Colistin Resistance Gene
    Li Y; Sun QL; Shen Y; Zhang Y; Yang JW; Shu LB; Zhou HW; Wang Y; Wang B; Zhang R; Wang S; Shen Z
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29386265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of bloodstream infections caused by six key antibiotic-resistant pathogens for prioritization of research and discovery of new therapies in Europe: a systematic review.
    Pezzani MD; Arieti F; Rajendran NB; Barana B; Cappelli E; De Rui ME; Galia L; Hassoun-Kheir N; Argante L; Schmidt J; Rodriguez-Bano J; Harbarth S; de Kraker M; Gladstone BP; Tacconelli E
    Clin Microbiol Infect; 2024 Mar; 30 Suppl 1():S4-S13. PubMed ID: 38007387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The determination of carbapenem resistance in Escherichia coli and Pneumoniae isolates related to nosocomial infections and the evaluation of risk factors.
    Budak S; Oncul O; Aktas Z; Acar A; Ozyurt M; Turhan V; Erdem H; Gorenek L
    Southeast Asian J Trop Med Public Health; 2014 Jan; 45(1):113-22. PubMed ID: 24964660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility profiles of Escherichia coli and Klebsiella pneumoniae isolated from outpatients in urban and rural districts of Uganda.
    Najjuka CF; Kateete DP; Kajumbula HM; Joloba ML; Essack SY
    BMC Res Notes; 2016 Apr; 9():235. PubMed ID: 27113038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.